International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. - Wikidata - awgldk - TriplyDB

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

http://www.wikidata.org/entity/Q33438403

about

TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.Castleman disease-associated diffuse parenchymal lung disease: A STROBE-compliant retrospective observational analysis of 22 cases in a tertiary Chinese hospital.TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.The full spectrum of Castleman disease: 273 patients studied over 20 years.Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.Castleman disease: delineating the spectrum.Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease.TAFRO syndrome: current perspectives.Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome.Unraveling Castleman: progress in a complex process.A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly.Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.Kaposi sarcoma-associated herpesvirus latency locus renders B cells hyperresponsive to secondary infections Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas A Case Report of Sarcoidosis Mimicking Vertebral Metastasis Human Herpesvirus 8 and Lymphoproliferative Disorders Biologic Agents in the Treatment of Multicentric Castleman Disease

P2860

Q33438812-9D101AC0-24B6-4A83-AB40-65CA5240B607 Q41678341-E74F38DF-A8CB-44BF-87B7-3A59C0DE0C6B Q41928805-5D8080D8-E792-4B5A-BD6D-D8BE4241AF0F Q42364525-D4F08BF9-3573-4525-8051-6C21254585CF Q47578601-770D0B9C-EBD1-4F58-89D8-754F261B83D5 Q47780672-EC454DCB-08F7-4529-BDEF-03423E185BDA Q48294900-FD652F9C-2988-4CA9-AE7F-59ABF28DDFA4 Q49165989-260A94EB-C1A4-4E72-A2CB-8E768C486853 Q49384282-F5DA1C4F-90A8-460D-A2D0-E7B82F80EFA0 Q50173216-AB31B95D-258E-46B5-BAD2-89F6908F5A66 Q50238394-3764D7A2-8E44-41D6-B0FD-9A44CEDD9140 Q52571131-CEDC4C6F-27E6-4FB1-8891-D17CF9FB78F4 Q52697349-E60E7439-A80A-4A03-A1E3-53373356FB7A Q52720139-8FADC644-91A1-47C1-8A38-1B420319CC2B Q54594948-0A1642D9-23E3-4A62-A9FB-4F0A138923A6 Q55024047-D8DE6FF4-CCBD-4E73-A88A-3C633BE8BF9B Q56345322-3F063F83-35DC-42EE-844E-FD57B3BC9C53 Q56594773-776EF292-109D-4CF9-B3F6-B1D13F8E4DCE Q57115475-D6001681-863D-4639-9BB9-713C4FAC61B2 Q58701113-83DA66FD-BE1E-4116-851F-F6EBDD48592D Q59137206-B401458C-F4B0-45EF-B59D-5AC10DB77164

P2860

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

http://www.wikidata.org/entity/Q33438403

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

International, evidence-based ...... ulticentric Castleman disease.

@ast

International, evidence-based ...... ulticentric Castleman disease.

@en

type

label

International, evidence-based ...... ulticentric Castleman disease.

@ast

International, evidence-based ...... ulticentric Castleman disease.

@en

prefLabel

International, evidence-based ...... ulticentric Castleman disease.

@ast

International, evidence-based ...... ulticentric Castleman disease.

@en

P1433

Q33438403-776631FB-19A0-4A2B-8659-4F12A858A19C

P1476

Q33438403-86D6A362-08C1-47C2-AE6B-53CF9B4A7A74

P2093

Q33438403-004C8A5F-A8C1-4E23-82DF-A567C83DA1F2

Q33438403-1A145ECB-CF56-4120-9E4C-8C3DAFA50BC3

Q33438403-2271D348-E40B-44A8-AC6B-C6165A04B827

Q33438403-252DD34A-DEB5-4AD6-AF1A-68CE84F782C8

Q33438403-348DB58D-FBDD-403F-80FC-3F1DD6604417

Q33438403-41A5503A-EEC3-4126-8E97-60985FE2B6AB

Q33438403-432D2A7B-590A-4687-8E2F-731ADC09A7FD

Q33438403-4774AE48-D2BD-4056-9C61-DB6A4A10B890

Q33438403-4B46F602-AA61-4215-A19C-5D2E91C31691

Q33438403-55B6C390-793F-4E52-B2AB-870746BF8E86

P2860

Q33438403-01E1B601-7EB3-45E7-8194-EF0F6A7EF246

Q33438403-04FD677A-F163-41CF-A5E2-848612920D73

Q33438403-08606BBA-E589-44F4-804A-1825E4B2B7BB

Q33438403-0B5F76CE-0EE0-44EA-A700-EBB4A6E74776

Q33438403-103E97F3-916E-4B06-84EC-F30172D20BD2

Q33438403-18DAC34C-0670-4805-8E6F-494C0D45158E

Q33438403-1CB82398-8844-4BAA-846F-2476D2F6464B

Q33438403-1E1A7574-42AA-467C-B0E3-448364C9C503

Q33438403-1F036036-53A7-49BD-B4D1-1ACDB8D12D93

Q33438403-293916B0-E271-4E0C-AE1F-449BE4FBD65B

P304

Q33438403-9B11ED7B-E301-446A-9A9A-832135B48C8A

P31

Q33438403-E7A0FFC0-EEE7-4250-A2AC-B563A44AE8FD

P356

Q33438403-AAAC2886-23B1-41F3-846C-0F2DCD6B2327

P407

Q33438403-AAB0E412-6879-4173-9ACE-8C4978D90C61

P433

Q33438403-B549E0DD-42EF-4619-8A5A-5B5DC5D5096A

P478

Q33438403-7E149A40-6516-4E5D-BC7C-759C0F7B319A

P50

Q33438403-0955CA3A-E265-47FB-8DB7-17DED53A7988

Q33438403-2628E7D6-BAD4-4E40-BEBE-6528D76DD5D9

Q33438403-311643DF-A927-4BE1-933B-5C60622CB729

Q33438403-5EF0F308-B122-4D12-A2F9-70C173A794F4

Q33438403-771AC46C-A4D2-49AA-9059-DA0DF6AF64D1

Q33438403-8644F593-3F8C-47D9-84A1-E15A063740C9

P577

Q33438403-DF9FB317-A3E1-4DD8-88F4-69CA9CAD31CE

P698

Q33438403-24D67B2C-8503-4578-879C-AFD624678224

P932

Q33438403-AF8EF8C7-F915-44B6-9A2F-5ED37A94FE4A

P356

BLOOD-2016-10-746933

P1433

P1476

International, evidence-based ...... ulticentric Castleman disease.

@en

P2093

Adam Bagg

http://www.w3.org/2001/XMLSchema#string

Ahmet Dogan

http://www.w3.org/2001/XMLSchema#string

Alexander Fosså

http://www.w3.org/2001/XMLSchema#string

Alexander Suarez

http://www.w3.org/2001/XMLSchema#string

Amy Chadburn

http://www.w3.org/2001/XMLSchema#string

Christopher S Nabel

http://www.w3.org/2001/XMLSchema#string

Corey Casper

http://www.w3.org/2001/XMLSchema#string

Dale Frank

http://www.w3.org/2001/XMLSchema#string

David Menke

http://www.w3.org/2001/XMLSchema#string

David Simpson

http://www.w3.org/2001/XMLSchema#string

P2860

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease

Lack of cytogenetic abnormalities in Castleman's disease.

Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.

[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].

Autoimmune cytopenias in Castleman's disease.

Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.

P304

1646-1657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-10-746933

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Angela Dispenzieri

Alexander Fosså

David Fajgenbaum

Razelle Kurzrock

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28087540

http://www.w3.org/2001/XMLSchema#string

P932

5364342

http://www.w3.org/2001/XMLSchema#string